Education
About Us
Working with TipRanks
Follow Us
Rhythm Pharmaceuticals Inc (RYTM)
NASDAQ:RYTM
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 189.76M | $ 130.13M | $ 77.43M | $ 23.64M | $ 3.15M |
| Gross Profit | $ 170.26M | $ 116.76M | $ 68.13M | $ 21.50M | $ 2.56M |
| Operating Income | $ -192.02M | $ -265.50M | $ -184.36M | $ -179.16M | $ -170.06M |
| EBITDA | $ -174.12M | $ -238.09M | $ -168.46M | $ -174.25M | $ -68.45M |
| Net Income | $ -201.92M | $ -260.60M | $ -184.68M | $ -181.12M | $ -69.61M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 388.95M | $ 320.56M | $ 275.85M | $ 333.29M | $ 294.86M |
| Total Assets | $ 480.20M | $ 392.27M | $ 332.75M | $ 382.48M | $ 329.52M |
| Total Debt | $ 3.99M | $ 3.94M | $ 1.26M | $ 1.94M | $ 2.55M |
| Net Debt | $ -50.31M | $ -85.20M | $ -58.82M | $ -125.73M | $ -56.70M |
| Total Liabilities | $ 210.17M | $ 227.72M | $ 162.99M | $ 118.22M | $ 45.37M |
| Stockholders' Equity | $ 139.07M | $ 164.55M | $ 169.76M | $ 264.26M | $ 284.15M |
| Cash Flow | |||||
| Free Cash Flow | $ -116.63M | $ -113.88M | $ -136.20M | $ -177.71M | $ -151.44M |
| Operating Cash Flow | $ -115.67M | $ -113.88M | $ -136.16M | $ -173.43M | $ -146.00M |
| Investing Cash Flow | $ -137.15M | $ -48.17M | $ -5.67M | $ 28.03M | $ -62.16M |
| Financing Cash Flow | $ 217.96M | $ 191.24M | $ 74.37M | $ 213.83M | $ 166.48M |